Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Nature|July 19, 2001
Evidence for fault weakness and fluid flow within an active low-angle normal faultJ S Floyd, J C Mutter, A M Goodliffe, et al.Diabetologia|June 26, 2013
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapyS Wheeler, K Moore, C W Forsberg, et al.Diabetes, Obesity & Metabolism|July 17, 2015
Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and strokeJ S Floyd, K L Wiggins, C M Sitlani, et al.Clinical Pharmacology and Therapeutics|March 16, 2012
A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrelJ S Floyd, R Kaspera, K D Marciante, et al.Journal of Thrombosis and Haemostasis : JTH|April 11, 2016
The association of statin therapy with the risk of recurrent venous thrombosisN L Smith, L B Harrington, M Blondon, et al.The Pharmacogenomics Journal|December 7, 2019
Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestryLisa de las Fuentes, Y J Sung, C M Sitlani, et al.The Pharmacogenomics Journal|December 14, 2016
Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working GroupJ S Floyd, C M Sitlani, C L Avery, et al.The Pharmacogenomics Journal|July 19, 2017
Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiologyA A Seyerle, C M Sitlani, R Noordam, et al.Pageof 1